Tens of thousands could benefit from one-minute cancer jab on the NHS
- Stephen Caldwell

- May 3
- 1 min read
The immunotherapy injection works by telling the body’s immune system to recognise and kill cancer cells and is powerful against several types of the disease, including lung, breast, head and neck, and cervical cancer.
Until now, patients have had to spend long periods on a drip to get the drug pembrolizumab (Keytruda) into their system.
A new injectable form means the time needed for treatment can be slashed by up to 90%.
One of the first patients to receive the new injection on the NHS was 89-year-old Shirley Xerxes from St Albans in Hertfordshire, who has bowel cancer.
She was treated at the Mount Vernon Cancer Centre, part of East and North Hertfordshire Teaching NHS Trust.
Article courtesy of Perspective Media
















Comments